are there natural glp-1 agonists GLP-1: Genetic Variants Related to RA Medications GLP-1 Drugs and Eating Disorders:

A phase 2, randomized, dose-finding study of the novel once-weekly human glp-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes

A: Wegovy (semaglutide at higher dose) and Mounjaro (tirzepatide) have received approval for obesity management in adults with BMI 30 (or 27 with metabolic complications)

Muscle Mass Reduction Studies indicate that up to 40% of weight loss on some GLP-1 medications can actually be lean muscle rather than fat tissue

Multiple medications now exist, each with slightly different properties

However, enthusiasm for it has been declining, as outcomes in earlier reports have not been replicated in newer ones

36 Furthermore, DDIs between levothyroxine and oral semaglutide, caused by delayed gastric emptying, have been explored (Table 5)